Gastrointestinal cancer: Rationale for metronomic chemotherapy in phase III trials

Robert S. Kerbel; Axel Grothey

doi:10.1038/nrclinonc.2015.89

Gastrointestinal cancer: Rationale for metronomic chemotherapy in phase III trials

Robert S. Kerbel, Axel Grothey

Medical Oncology

Research output: Contribution to journal › Short survey › peer-review

16 Scopus citations

Original language	English (US)
Pages (from-to)	313-314
Number of pages	2
Journal	Nature Reviews Clinical Oncology
Volume	12
Issue number	6
DOIs	https://doi.org/10.1038/nrclinonc.2015.89
State	Published - Jun 30 2015

ASJC Scopus subject areas

Oncology

Access to Document

10.1038/nrclinonc.2015.89

Cite this

@article{085b1bc1b3504560a0bf8a31ee6265f6,

title = "Gastrointestinal cancer: Rationale for metronomic chemotherapy in phase III trials",

author = "Kerbel, {Robert S.} and Axel Grothey",

year = "2015",

month = jun,

day = "30",

doi = "10.1038/nrclinonc.2015.89",

language = "English (US)",

volume = "12",

pages = "313--314",

journal = "Nature Reviews Clinical Oncology",

issn = "1759-4774",

publisher = "Nature Publishing Group",

number = "6",

}

TY - JOUR

T1 - Gastrointestinal cancer

T2 - Rationale for metronomic chemotherapy in phase III trials

AU - Kerbel, Robert S.

AU - Grothey, Axel

PY - 2015/6/30

Y1 - 2015/6/30

UR - http://www.scopus.com/inward/record.url?scp=84930181366&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84930181366&partnerID=8YFLogxK

U2 - 10.1038/nrclinonc.2015.89

DO - 10.1038/nrclinonc.2015.89

M3 - Short survey

C2 - 25963090

AN - SCOPUS:84930181366

SN - 1759-4774

VL - 12

SP - 313

EP - 314

JO - Nature Reviews Clinical Oncology

JF - Nature Reviews Clinical Oncology

IS - 6

ER -

Gastrointestinal cancer: Rationale for metronomic chemotherapy in phase III trials

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this